Ramucirumab for treating advanced gastric cancer or gastro–oesophageal junction adenocarcinoma previously treated with chemotherapy

Equality Impact Assessment (Guidance development) (PDF 173 KB)

Final appraisal determination

Final appraisal determination document (PDF 446 KB)

Committee papers (PDF 1.08 MB)

Appraisal consultation

Committee papers information

Committee papers (PDF 9.3 MB)

Appraisal consultation document (PDF 434 KB)

Final scope (PDF 95 KB)

Final matrix (PDF 35 KB)

NICEs response to comments on the draft scope and provisional matrix (PDF 148 KB)

Equality impact assessment (PDF 120 KB)

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): provisional matrix (pre-referral) July 2014 (PDF 102 KB)

Gastric cancer (metastatic) - ramucirumab (after chemotherapy): draft scope for consultation (pre-referral) July 2014 (PDF 105 KB)